Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies

Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies

US Patent 10017578 · Granted Jul 10, 2018

Estimated economic value: $27,313,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interleukin-15 (IL-15) fusion proteins and uses thereof2025
Cytokine-based bioactivatable drugs and methods of uses thereof2025
Interleukin-2 variants and methods of uses thereof2024
Anti-CD19 antibodies and uses therof2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Anti-CD123 antibodies and conjugates and derivatives thereof2024
Anti-CD123 antibodies and conjugates and derivatives thereof2024